These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

880 related articles for article (PubMed ID: 27167345)

  • 1. Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1.
    Song Y; Li X; Zeng Z; Li Q; Gong Z; Liao Q; Li X; Chen P; Xiang B; Zhang W; Xiong F; Zhou Y; Zhou M; Ma J; Li Y; Chen X; Li G; Xiong W
    Oncotarget; 2016 Jun; 7(24):36783-36799. PubMed ID: 27167345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-encoded miR-BART11 promotes tumor-associated macrophage-induced epithelial-mesenchymal transition via targeting FOXP1 in gastric cancer.
    Song Y; Li Q; Liao S; Zhong K; Jin Y; Zeng T
    Virology; 2020 Sep; 548():6-16. PubMed ID: 32530809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1.
    Wang J; Ge J; Wang Y; Xiong F; Guo J; Jiang X; Zhang L; Deng X; Gong Z; Zhang S; Yan Q; He Y; Li X; Shi L; Guo C; Wang F; Li Z; Zhou M; Xiang B; Li Y; Xiong W; Zeng Z
    Nat Commun; 2022 Feb; 13(1):866. PubMed ID: 35165282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell proliferation through the LOC553103-STMN1 axis.
    Wang D; Zeng Z; Zhang S; Xiong F; He B; Wu Y; Li W; Tang L; Wei F; Xiang B; Li Z; Zhou Y; Zhou M; Li X; Li Y; Li G; Xiong W; Guo C
    FASEB J; 2020 Jun; 34(6):8012-8027. PubMed ID: 32306460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
    Zheng X; Wang J; Wei L; Peng Q; Gao Y; Fu Y; Lu Y; Qin Z; Zhang X; Lu J; Ou C; Li Z; Zhang X; Liu P; Xiong W; Li G; Yan Q; Ma J
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation network and expression profiles of Epstein-Barr virus-encoded microRNAs and their potential target host genes in nasopharyngeal carcinomas.
    Zeng Z; Huang H; Huang L; Sun M; Yan Q; Song Y; Wei F; Bo H; Gong Z; Zeng Y; Li Q; Zhang W; Li X; Xiang B; Li X; Li Y; Xiong W; Li G
    Sci China Life Sci; 2014 Mar; 57(3):315-326. PubMed ID: 24532457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis.
    Shinozaki-Ushiku A; Kunita A; Isogai M; Hibiya T; Ushiku T; Takada K; Fukayama M
    J Virol; 2015 May; 89(10):5581-91. PubMed ID: 25740983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
    Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
    Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ARID1A deficiency in EBV-positive gastric cancer is partially regulated by EBV-encoded miRNAs, but not by DNA promotor hypermethylation.
    Kase K; Saito M; Nakajima S; Takayanagi D; Saito K; Yamada L; Ashizawa M; Nakano H; Hanayama H; Onozawa H; Okayama H; Endo H; Fujita S; Sakamoto W; Saze Z; Momma T; Mimura K; Ohki S; Shiraishi K; Kohno T; Kono K
    Carcinogenesis; 2021 Feb; 42(1):21-30. PubMed ID: 33196828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma.
    Lung RW; Hau PM; Yu KH; Yip KY; Tong JH; Chak WP; Chan AW; Lam KH; Lo AK; Tin EK; Chau SL; Pang JC; Kwan JS; Busson P; Young LS; Yap LF; Tsao SW; To KF; Lo KW
    J Pathol; 2018 Apr; 244(4):394-407. PubMed ID: 29230817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC.
    Yan Q; Zeng Z; Gong Z; Zhang W; Li X; He B; Song Y; Li Q; Zeng Y; Liao Q; Chen P; Shi L; Fan S; Xiang B; Ma J; Zhou M; Li X; Yang J; Xiong W; Li G
    Oncotarget; 2015 Dec; 6(39):41766-82. PubMed ID: 26497204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma.
    Cheung CC; Lun SW; Chung GT; Chow C; Lo C; Choy KW; Lo KW
    BMC Cancer; 2016 Jul; 16():495. PubMed ID: 27431799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EBV-miR-BART12 accelerates migration and invasion in EBV-associated cancer cells by targeting tubulin polymerization-promoting protein 1.
    Wu Y; Wang D; Wei F; Xiong F; Zhang S; Gong Z; Shi L; Li X; Xiang B; Ma J; Deng H; He Y; Liao Q; Zhang W; Li X; Li Y; Guo C; Zeng Z; Li G; Xiong W
    FASEB J; 2020 Dec; 34(12):16205-16223. PubMed ID: 33094864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus-coded miR-BART13 promotes nasopharyngeal carcinoma cell growth and metastasis via targeting of the NKIRAS2/NF-κB pathway.
    Xu YJ; Zhou R; Zong JF; Lin WS; Tong S; Guo QJ; Lin C; Lin SJ; Chen YX; Chen MR; Chen HL; Ye YB; Pan JJ
    Cancer Lett; 2019 Apr; 447():33-40. PubMed ID: 30684592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eukaryotic initiating factor eIF4E is targeted by EBV-encoded miR-BART11-3p and regulates cell cycle and apoptosis in EBV-associated gastric carcinoma.
    Wang H; Liu J; Zhang Y; Sun L; Zhao M; Luo B
    Virus Genes; 2021 Aug; 57(4):358-368. PubMed ID: 34146250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
    Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
    J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive profiling of virus microRNAs of Epstein-Barr virus-associated gastric carcinoma: highlighting the interactions of ebv-Bart9 and host tumor cells.
    Tsai CY; Liu YY; Liu KH; Hsu JT; Chen TC; Chiu CT; Yeh TS
    J Gastroenterol Hepatol; 2017 Jan; 32(1):82-91. PubMed ID: 27144885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
    Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
    Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.
    Ma J; Nie K; Redmond D; Liu Y; Elemento O; Knowles DM; Tam W
    Leukemia; 2016 Mar; 30(3):594-604. PubMed ID: 26530011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.